FMR LLC 的 Form 4 申報
Structure Therapeutics Inc.（GPCR），2026/1/20 申報
- 申報編號
- 0001193125-26-016062
- 申報時間
- 2026/1/20
- 交易日
- 2026/1/15
- 申報延遲
- 5 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 8 筆衍生性交易。交易後 5 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| FMR LLCCIK 0000315066 | 持股 10% 以上大股東、其他：See Remark 1 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
這份申報沒有這一類的交易。
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/1/15 | Ordinary Shares | S賣出處分 | −1,395 | $82.10F2 | −$38,176.5 | 5,005 | 間接 | |
| 2026/1/15 | Ordinary Shares | S賣出處分 | −990 | $83.35F3 | −$27,505.5 | 4,675 | 間接 | |
| 2026/1/15 | Ordinary Shares | S賣出處分 | −1,656 | $84.22F4 | −$46,489.44 | 4,123 | 間接 | |
| 2026/1/15 | Ordinary Shares | S賣出處分 | −60 | $85.04F5 | −$1,700.8 | 4,103 | 間接 | |
| 2026/1/15 | Ordinary Shares | S賣出處分 | −16,431 | $82.10F2 | −$449,661.7 | 58,864 | 間接 | |
| 2026/1/15 | Ordinary Shares | S賣出處分 | −11,640 | $83.35F3 | −$323,398 | 54,984 | 間接 | |
| 2026/1/15 | Ordinary Shares | S賣出處分 | −19,494 | $84.22F4 | −$547,261.56 | 48,486 | 間接 | |
| 2026/1/15 | Ordinary Shares | S賣出處分 | −690 | $85.04F5 | −$19,559.2 | 48,256 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $82.00 to $82.37. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
表 II 有 2 筆交易的價格引用這則附註。
- F3
The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $83.00 to $83.84. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
表 II 有 2 筆交易的價格引用這則附註。
- F4
The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $84.00 to $84.64. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
表 II 有 2 筆交易的價格引用這則附註。
- F5
The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $85.02 to $85.06. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
表 II 有 2 筆交易的價格引用這則附註。
備註
Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Remark 3: F-Prime Capital Partners Life Sciences Advisors Fund VI LP (FPCPLSA) is the general partner of F-Prime Capital Partners Life Sciences Fund VI LP. FPCPLSA is solely managed by Impresa Management LLC, the managing member of its general partner and its investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family.